@article{bafe036ad6cb4d168c4a7ba9cb5bb978,
title = "Reply to E.M. Ruggeri et al and Y.-W. Hu",
author = "Galsky, {Matthew D.} and Erin Moshier and Juan Wisnivesky and Madhu Mazumdar",
note = "Funding Information: Supported by Grant No. 1R21CA176551-01A1 (M.D.G.); National Cancer Institute Cancer Center Support Grant No. P30 CA196521-01 (M.M.); and the Biostatistics Shared Resource Facility, Icahn School of Medicine at Mount Sinai, New York, NY. Janssen Oncology (Inst), Dendreon (Inst), Novartis (Inst), Bristol-Myers Squibb (Inst), Merck (Inst) Aventis Pharma (Inst), Quorum (Inst)",
year = "2016",
month = sep,
day = "10",
doi = "10.1200/JCO.2016.68.3052",
language = "English",
volume = "34",
pages = "3225--3226",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "26",
}